XML 54 R39.htm IDEA: XBRL DOCUMENT v3.26.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2025
Income Taxes [Abstract]  
Schedule of the Company’s Net deferred Tax Assets Significant components of the Company’s net deferred tax assets are as follows:
   As of December 31, 
   2025   2024 
   U.S. dollars
in thousands
 
Deferred tax assets        
Net operating loss carryforward  $8,778   $5,688 
Other temporary differences   54    95 
Capitalized research and development costs   1,257    1,282 
Operating lease liability   39    17 
Vacation and convalescence accrual   55    67 
           
Total deferred tax assets:   10,183    7,149 
           
Deferred tax liability: Operating lease right-of-use assets   (39)   (19)
           
Total deferred tax liability   (39)   (19)
           
Net deferred tax assets:   10,144    7,130 
Less: Valuation allowance   (10,144)   (7,130)
           
Net deferred tax asset   -    - 
Schedule of the Movement of the Valuation Allowance

The movement of the valuation allowance (through income statement) is as follows:

 

   For the year ended December 31, 
   2025   2024   2023 
   U.S. dollars in thousands 
             
Balance at the beginning of the year   7,130    4,829    3,016 
Addition of valuation allowance   3,014    2,301    1,813 
                
Net change in the valuation allowance   3,014    2,301    1,813 
                
Balance at the end of the year   10,144    7,130    4,829